Dr. Pieczonka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1226 E Water St
Syracuse, NY 13210Phone+1 315-478-4185Fax+1 315-478-0840- Is this information wrong?
Education & Training
University at BuffaloResidency, Urology, 1999 - 2003- University at BuffaloResidency, Surgery, 1997 - 1999
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1997
Certifications & Licensure
NY State Medical License 2002 - 2024- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2012
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsBone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerArif Hussain, Abhishek Tripathi, Christopher Michael Pieczonka, Diane Cope, Andrea McNatty, Christopher J. Logothetis, Theresa A. Guise> ;Prostate Cancer and Prostatic Diseases. 2021 Jun 1
- 7 citationsOptimizing the management of castration‐resistant prostate cancer patients: A practical guide for cliniciansNeal D. Shore, Charles G. Drake, Daniel W. Lin, Charles J. Ryan, Kelly L. Stratton, Curtis Dunshee, Lawrence Karsh, Sanjeev Kaul, Ken Kernen, Christopher Michael Piecz...> ;The Prostate. 2020 Aug 11
- 30 citationsThe Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients wi...David P. Dearnaley, Daniel Saltzstein, John Sylvester, Lawrence Karsh, Bryan A. Mehlhaff, Christopher Michael Pieczonka, James Bailen, Hongliang Shi, Zhan Ye, Hélène M...> ;European Urology. 2020 Aug 1
- Join now to see all
Hospital Affiliations
Crouse HealthSyracuse, New York
St. Joseph's Hospital Health CenterSyracuse, New York
Upstate University HospitalSyracuse, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
